12 February, 2021
The EU-JAMRAI Final Conference gathered key speakers from the Antimicrobial Resistance (AMR) field. With the participation of institutions such as DG Santé, WHO, ECDC, EMA and EFSA, among others, the Joint Action presented the results of three and a half years of work, as well as key recommendations to tackle antibiotic resistance.
27 January, 2021
Medicine shortages are a common problem that have been exacerbated by COVID-19 due to increased demand of some medicines and supply disruptions due to lockdowns and border closures. Shortages of antibiotics are particularly disruptive.
29 December, 2020
Micro-Combat game App was developed by the European Joint Action on Antimicrobial Resistance (AMR) and Healthcare-Associated Infections (HCAI), EU-JAMRAI, with the aim of providing specific knowledge on antimicrobial resistance and improving the correct use of antibiotics among youngest generations
17 November, 2020
EU-JAMRAI presents the first global symbol to raise awareness of the threat of antibiotic resistance
The Antibiotic Resistance Symbol has been selected in a design contest launched by the European Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI)
18 November, 2019
EU-JAMRAI launches, during the celebration of the European Antibiotic Awareness Day (EAAD) in Stockholm, a design contest to find the symbol that best represents the global threat of antibiotic resistance.
15 November, 2018
EU-JAMRAI joins the international actions on the European Awareness Antibiotic Day with an online video campaign to raise awareness about the importance of always following the instructions of the healthcare professional
9 November, 2018
EU-JAMRAI joins the international actions on the European Awareness Antibiotic Day with an online video campaign to raise awareness about the importance of always following the instructions of the healthcare professional
25 April, 2018
The Joint Action on Antimicrobial Resistance and Healthcare Associated Infections (EU-JAMRAI) participated in the 28th European Congress of Clinical Microbiology and Infectious Diseases with a stand financed by CHAFEA.